Ado-trastuzumab emtansine, trade name kadcyla

Overview of Kadcyla

APIs

API Suppliers

0

US DMFs Filed

0

CEP/COS Certifications

0

JDMFs Filed

0

Other Certificates

0

Other Suppliers

0

FINISHED FORMULATIONS

USA (Orange Book)

Europe

Canada

Australia

South Africa

0

Uploaded Dossiers

0

GLOBAL SALES (USD $ Million)

U.S. Medicaid

Annual Reports

0

API REFERENCE PRICE (USD/KG)

0

MARKET PLACE

API

0

FDF

NEWS AND BLOGS

News

0

Blog

0

REFERENCE STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

RELATED LINKS

Excipients

Intermediates

0

Analytical Solutions

0

Services

0

Dossiers// Finished Dosage Formulations

  • VIEW ALL FDFS

    10

    View All Dossiers for ado-trastuzumab emtans...

  • FDA ORANGE BOOK

    2

    View US FDA Orange Book approvals for ado-tr...

  • EUROPE

    2

    View European Marketing Authorizations grant...

  • CANADA

    2

    View Health Canada approvals for ado-trastuz...

  • AUSTRALIA

    4

    View TGA approvals for ado-trastuzumab emtan...

Related Excipients?

  • All Excipients

    4

    View all Excipient Product Catalog for ado-trastuz...

  • View all Excipient Product Catalog of Seppic

  • View all Excipient Product Catalog of BASF

  • View all Excipient Product Catalog of Pfanstiehl, ...

Excipients By Applications?

  • Topical

    1

    View all Excipient Product Catalog of Topical

  • Solubilizers

    3

    View all Excipient Product Catalog of Solubilizers

  • Parenteral

    1

    View all Excipient Product Catalog of Parenteral

  • Thickeners and Stabilizers

    1

    View all Excipient Product Catalog of Thickeners a...

  • Surfactant & Foaming Agents

    1

    View all Excipient Product Catalog of Surfactant &...

Indian Import/Export Trade Data

Global Sales Information

  • U.S. MEDICAID PRESCRIPTIONS

    1

    View Sales Data from US Prescriptions for ad...

Media

  • NEWS

    42

    Read the Latest News about ado-trastuzumab e...